Overview

A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers

Status:
NOT_YET_RECRUITING
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-116 and the administration of AD-1161 in healthy adult male volunteers
Phase:
PHASE1
Details
Lead Sponsor:
Addpharma Inc.